Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir-HU in Asymptomatic to Mild COVID-19
NCT04940871Phase 2Terminated
- Sponsor
- University of Pécs
- Start
- Nov 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by University of Pécs. Started Nov 2021; status: terminated.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04940871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940871.